Sleep during titration predicts continuous positive airway pressure compliance

Sleep

Volumn 26, Issue 3, 2003, Pages 308-311

  Drake, Christopher L ^a   Day, Ryan ^a   Hudgel, David ^a   Stefadu, Yevgeniy ^a   Parks, Mary ^a   Syron, Mary Lou ^a   Roth, Thomas ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; FOLLOW UP; HUMAN; HYPOTHESIS; MEASUREMENT; MULTIVARIATE ANALYSIS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; SEQUENTIAL ANALYSIS; SLEEP; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; TITRIMETRY; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; PHYSIOLOGY; SLEEP STAGE; STATISTICS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE-PRESSURE RESPIRATION; PROSPECTIVE STUDIES; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES;

EID: 0042853171     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/26.3.308     Document Type: Article

References (37)

1. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
2. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: An objective evaluation of patient compliance. Am J Respir Crit Care Med 1994;149:149-54.
3. Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy m obstructive sleep apnea patients and in snorers. Sleep 1996;19:S136-43
4. Krieger J, Kurtz D. Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnoea syndrome. Eur Respir J 1988;1:436-8.
5. Noseda A, Jann E, Hoffmann G, Linkowski P, Kerkhofs M. Compliance with nasal continuous positive airway pressure assessed with a pressure monitor: pattern of use and influence of sleep habits. Respir Med 2000;94:76-81.
6. Meurice JC, Dore P, Paquereau J, Neau JP, Ingrand P, Chavagnat JJ, Patte F. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994;105:429-33
7. Waldhorn RE, Herrick TW, Nguyen MC, O'Donnell AE, Sodero J, Potolicchio SJ. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990;97:33-8.
8. Aloia MS, Di Dio L, Ilniczky N, Perlis ML, Greenblatt DW, Giles DE. Improving compliance with nasal CPAP and vigilance in older adults with oahs. Sleep Breath 2001;5:13-21.
9. Meurice JC, Paquereau J, Neau JP, et al. Long-term evolution of daytime somnolence in patients with sleep apnea/hypopnea syndrome treated by continuous positive airway pressure Sleep 1997;20:1162-6.
10. Pressman MR, Peterson DD, Meyer TJ, Harkins JP, Gurijala L. Ramp abuse. A novel form of patient noncompliance to administration of nasal continuous positive airway pressure for treatment of obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:1632-4.
11. Strollo PJ Jr, Sanders MH, Costantino JP, Walsh SK, Stiller RA, Atwood CW, Jr. Split-night studies for the diagnosis and treatment of sleep-disordered breathing. Sleep 1996;19:S255-9.
12. Weaver TE, Kribbs NB, Pack AI, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997;20:278-83.
13. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999;116:403-8.
14. Likar LL, Panciera TM, Erickson AD, Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest 1997;111:1273-7.
15. Kribbs NB, Pack Al, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea Am Rev Respir Dis 1993;147:887-95
16. Drake CL, Roehrs TA, Burduvali E, Bonahoom A, Rosekind M, Roth T Effects of rapid versus slow accumulation of eight hours of sleep loss. Psychophysiology 2001;38:979-87
17. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996;109:1470-6.
18. Sforza E, Lugaresi E. Daytime sleepiness and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome patients: effects of chronic treatment and 1-night therapy withdrawal. Sleep 1995;18:195-201.
19. Zozula R, Rosen R. Compliance with continuous positive airway pressure therapy assessing and improving treatment outcomes. Curr Opin Pulm Med 2001;7:391-8
20. Hui DS, Chan JK, Choy DK, et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a chinese population. Chest 2000;117:1410-6
21. Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997;20:284-9.
22. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea hypopnea syndrome? Am J Respir Crit Care Med 1999;159:1096-100
23. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study Chest 2002;121:430-5.
24. Wiest GH, Ficker JH. Humidification during continuous positive airway pressure therapy Chest 2000;117:925.
25. Hudgel DW, Fung C. A long-term randomized, cross-over comparison of auto-titrating and standard nasal continuous airway pressure. Sleep 2000;23:645-8.
26. Stepnowsky Jr. CJ, Bardwell WA, Moore PJ, Ancoli-Israel S, Dimsdale JE. Psychologic correlates of compliance with continuous positive airway pressure. Sleep 2002;25:758-62.
27. Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep 1992;15:S42-6.
28. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:1108-14.
29. Edinger JD, Carwile S, Miller P, Hope V, Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea. Percept Mot Skills 1994;78:1116-8.
30. Ball EM, Banks MB. Determinants of compliance with nasal continuous positive airway pressure treatment applied in a community setting. Sleep Med 2001;2:195-205.
31. van de Mortel TF, Laird P, Jarrett C. Client perceptions of the polysomnography experience and compliance with therapy. Contemp Nurse 2000;9:161-8.
32. Janson C, Noges E, Svedberg-Randt S, Lindberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med 2000;94:145-9
33. Jokic R, Klimaszewski A, Sridhar G, Fitzpatrick MF. Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea. Chest 1998;114:1061-9.
34. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/ Brain Research Institute, UCLA, 1968.
35. Saucier G Mini-markers: A brief version of Goldberg's unipolar big-five markers. J Pers Assess 1994;63:506-16.
36. Kribbs NB, Pack AI, Kline LR, et al Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:1162-8.
37. Engleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep 2000;23 Suppl 4:S102-8.